Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Pharmacology and pharmacokinets of imatinib in pediatric patients (Suttorp M et al. Expert Rev Clin Pharmacol, Nov 2017)

Expert Rev Clin Pharmacol, November 2017 
Suttorp M et al

Temporal trends in the proportion of "cure" in children and young adults diagnosed with chronic myeloid leukaemia in England: a population-based study (Drozdov D et al. Pediatr Blood Cancer, August 2018)

Pediatr Blood Cancer, August 2018 (epub ahead of print)
Drozdov D et al. 

Prognostic discrimination based on the EUTOS long term survival score within the international registry for chronic myeloid leukemia in children and adolescents (Millot F et al. Haematologica, August 2017)

Haematologica, August 2017 
Millot F et al

Dasatinib-induced Hypopigmentation in pediatric patient with chronic myeloid leukemia: A Case Report and review of the literature

Case Report Dermatol Med, July 2018 
Alharbi B et al. 

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

Leukemia, June 2018 
Suttorp M et al. 

  1. The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy (Samis J et al. Pediatr Blood Cancer, July 2017)
  2. Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia (Ernst T et al. Leukemia, June 2018)
  3. Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (Millot F et al. Cancer, May 2017)
  4. Death within 1 month of diagnosis in childhood cancer: an analysis of risk factors and scope of the problem (Green A et al. J Clin Oncol, March 2017)